18:09 IST
BSE
Results Correction
Sudarshan Pharma Industries Results Correction
Sudarshan Pharma re-submitted its audited FY26 financial results to address BSE discrepancies. The filing ensures regulatory compliance and provides corrected standalone and consolidated performance data.